Publications | PubMed=3855324; DOI=10.1288/00005537-198501000-00012 Baker S.R. An in vivo model for squamous cell carcinoma of the head and neck. Laryngoscope 95:43-56(1985) PubMed=1394225 Somers K.D., Merrick M.A., Lopez M.E., Incognito L.S., Schechter G.L., Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res. 52:5997-6000(1992) DOI=10.1016/B978-0-12-333530-2.50007-1 Carey T.E. Head and neck tumor cell lines. (In book chapter) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.79-120; Academic Press; New York; USA (1994) PubMed=8679156; DOI=10.1007/BF00178278 Koldovsky P., Haas I., Bier H., Ganzer U. Immunohistochemical examination of 11 cell lines derived from human head and neck squamous cell carcinomas, their recurrences or metastases. Eur. Arch. Otorhinolaryngol. 252:359-365(1995) PubMed=8552396 Patel A.M., Incognito L.S., Schechter G.L., Wasilenko W.J., Somers K.D. Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines. Oncogene 12:31-35(1996) PubMed=12884349; DOI=10.1002/hed.10274 Bradford C.R., Zhu S.-B., Ogawa H., Ogawa T., Ubell M., Narayan A., Johnson G., Wolf G.T., Fisher S.G., Carey T.E. p53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head Neck 25:654-661(2003) PubMed=15287027; DOI=10.1002/gcc.20066 Takebayashi S., Hickson A., Ogawa T., Jung K.-Y., Mineta H., Ueda Y., Grenman R., Fisher S.G., Carey T.E. Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer. Genes Chromosomes Cancer 41:145-154(2004) PubMed=15495191; DOI=10.1002/gcc.20119 Raschke S., Balz V., Efferth T., Schulz W.A., Florl A.R. Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines. Genes Chromosomes Cancer 42:58-67(2005) PubMed=16020667; DOI=10.1158/1535-7163.MCT-05-0081 Bauer J.A., Trask D.K., Kumar B., Los G., Castro J., Lee J.S.-J., Chen J.-Y., Wang S.-M., Bradford C.R., Carey T.E. Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL. Mol. Cancer Ther. 4:1096-1104(2005) PubMed=16331601; DOI=10.1002/ijc.21514 Muller A., Sonkoly E., Eulert C., Gerber P.A., Kubitza R., Schirlau K., Franken-Kunkel P., Poremba C., Snyderman C.H., Klotz L.-O., Ruzicka T., Bier H., Zlotnik A., Whiteside T.L., Homey B., Hoffmann T.K. Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy. Int. J. Cancer 118:2147-2157(2006) PubMed=17312569; DOI=10.1002/hed.20478 Lin C.J., Grandis J.R., Carey T.E., Gollin S.M., Whiteside T.L., Koch W.M., Ferris R.L., Lai S.Y. Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head Neck 29:163-188(2007) PubMed=18487078; DOI=10.1016/j.oraloncology.2008.02.006 Hoffmann T.K., Sonkoly E., Hauser U., van Lierop A., Whiteside T.L., Klussmann J.P., Hafner D., Schuler P.J., Friebe-Hoffmann U., Scheckenbach K., Erjala K., Grenman R., Schipper J., Bier H., Balz V. Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma. Oral Oncol. 44:1100-1109(2008) PubMed=19760794; DOI=10.1002/hed.21198; PMCID=PMC3292176 Brenner J.C., Graham M.P., Kumar B., Saunders L.M., Kupfer R., Lyons R.H., Bradford C.R., Carey T.E. Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines. Head Neck 32:417-426(2010) PubMed=20947470; DOI=10.1186/2047-783X-15-8-337; PMCID=PMC3458702 Schuler P.J., Trellakis S., Greve J., Bas M.B., Bergmann C., Bolke E., Lehnerdt G.F., Mattheis S., Albers A.E., Brandau S., Lang S.K., Whiteside T.L., Bier H., Hoffmann T.K. In vitro chemosensitivity of head and neck cancer cell lines. Eur. J. Med. Res. 15:337-344(2010) PubMed=21868764; DOI=10.1158/1078-0432.CCR-11-0690; PMCID=PMC3229662 Zhao M., Sano D., Pickering C.R., Jasser S.A., Henderson Y.C., Clayman G.L., Sturgis E.M., Ow T.J., Lotan R., Carey T.E., Sacks P.G., Grandis J.R., Sidransky D., Heldin N.-E., Myers J.N. Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites. Clin. Cancer Res. 17:7248-7264(2011) PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076 Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P., Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B., Liang H. Characterization of human cancer cell lines by reverse-phase protein arrays. Cancer Cell 31:225-239(2017) PubMed=29156801; DOI=10.18632/oncotarget.21174; PMCID=PMC5689691 Kalu N.N., Mazumdar T., Peng S.-H., Shen L., Sambandam V., Rao X.-Y., Xi Y.-X., Li L.-R., Qi Y., Gleber-Netto F.O., Patel A., Wang J., Frederick M.J., Myers J.N., Pickering C.R., Johnson F.M. Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines. Oncotarget 8:86369-86383(2017) PubMed=31090975; DOI=10.1002/hed.25803; PMCID=PMC6692232 Mann J.E., Kulkarni A., Birkeland A.C., Kafelghazal J., Eisenberg J., Jewell B.M., Ludwig M.L., Spector M.E., Jiang H., Carey T.E., Brenner J.C. The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel. Head Neck 41:3114-3124(2019) |